Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oran Ti Weikang tablets vs domperidone in functional dyspepsia
CTR20132371Phase 3Completed
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Start
- Feb 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 枳实总黄酮片 in functional dyspepsia (FD), sponsored by Jiangxi Qingfeng Pharmaceutical Co. Ltd.. Started Feb 2014; status: completed.
02
Drugs
枳实总黄酮片
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on CTR20132371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132371.